Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2018 · 83 citations · 20 references
Life SciencesNeurologyNeuroscienceDementiaNeurodegenerationNeuroimmunologyAlzheimer DiseaseBiomarkers Of NeurodegenerationCerebrospinal Fluid BiomarkersDementia BiomarkersNeurodegenerative DiseasesNeurodegenerative DisordersAmyloid Beta PeptidesCerebrospinal Fluid AnalysisCerebrospinal Fluid MarkersCerebrospinal Fluid TauEnzyme ImmunoassaysImmunoassaysInterlaboratory Method ComparisonTau Protein Biomarkers
Abstract Introduction An Elecsys® Amyloid β (Aβ [1–42]) immunoassay cutoff for classification of patients with Alzheimer's disease was investigated. Methods Cerebrospinal fluid samples collected from patients with mild‐to‐moderate Alzheimer's disease were analyzed by Elecsys® immunoassays: (1) Aβ (1–42), (2) total tau, and (3) phosphorylated tau. Cutoffs (Aβ [1–42] and ratios with tau) were estimated by method comparison between AlzBio3 ( n = 206), mixture modeling ( n = 216), and concordance with florbetapir F 18 imaging‐based classification ( n = 75). Results A 1065‐pg/mL (95% confidence interval: 985–1153) Elecsys® Aβ (1–42) cutoff provided 94% overall percentage agreement with AlzBio3. Comparable cutoff estimates (95% confidence interval) were derived from mixture modeling (equally weighted: 1017 [949–1205] pg/mL; prevalence weighted: 1172 [1081–1344] pg/mL) and concordance with florbetapir F 18 imaging (visual read: 1198 [998–1591] pg/mL; automated: 1198 [1051–1638] pg/mL). Discussion Based on three approaches, a 1100‐pg/mL Elecsys® Aβ (1–42) cutoff is suitable for clinical trials with similar populations and preanalytical handling.
20
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text
Medicine, Neurology, Neuroscience +14
The Jackknife Estimate of Variance
B. Efron, C. Stein · The Annals of Statistics · 1981 · 1.5K citations
2017 Alzheimer's disease facts and figures
Alzheimer s & Dementia · 2017 · 1.3K citations